24 HR Guanfacine 3 MG Extended Release Oral Tablet
1 INDICATIONS AND USAGE Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies ( 14 )] . Guanfacine extended-release is a central alpha 2A -adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications ( 1 , 14 ).
Actavis Pharma, Inc.
ROUND YELLOW 853
853 ROUND YELLOW
Related Pills
24 HR guanfacine 1 mg
Actavis Pharma, Inc.
24 HR guanfacine 1 MG Extended Release Oral Tablet
Actavis Pharma, Inc.
24 HR Guanfacine 3 MG Extended Release Oral Tablet
actavis pharma, inc.
24 HR Guanfacine 4 MG Extended Release Oral Tablet
Actavis Pharma, Inc.
24 HR Guanfacine 2 MG Extended Release Oral Tablet
Actavis Pharma, Inc.
24 HR Guanfacine 3 MG Extended Release Oral Tablet
Actavis Pharma, Inc.
guanfacine tablet extended release
actavis pharma, inc.
APAP 325 MG hydrocodone bitartrate 10 MG Oral Tablet
American Health Packaging
Acetaminophen 325 mg Hydrocodone 10 mg
Actavis Pharma, Inc.
Acetaminophen 325 mg Hydrocodone 10 mg
Actavis Pharma, Inc.
Acetaminophen 325 mg Hydrocodone 10 mg
Actavis Pharma, Inc.
Acetaminophen 325 mg Hydrocodone 10 mg
Actavis Pharma, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
GUANFACINE Extended-Release Tablets are available as follows: 1 mg - Each orange, round, unscored tablet debossed with on one side and 850 on the other side contains
GUANFACINE hydrochloride, USP equivalent to 1 mg of
GUANFACINE base. Tablets are supplied in bottles of 100 (NDC 0228-2850-11). 2 mg - Each orange, oval, unscored tablet debossed with on one side and 851 on the other side contains
GUANFACINE hydrochloride, USP equivalent to 2 mg of
GUANFACINE base. Tablets are supplied in bottles of 100 (NDC 0228-2851-11). 3 mg - Each yellow, round, unscored tablet debossed with on one side and 853 on the other side contains
GUANFACINE hydrochloride, USP equivalent to 3 mg of
GUANFACINE base. Tablets are supplied in bottles of 100 (NDC 0228-2853-11). 4 mg - Each yellow, oval, unscored tablet debossed with on one side and 855 on the other side contains
GUANFACINE hydrochloride, USP equivalent to 4 mg of
GUANFACINE base. Tablets are supplied in bottles of 100 (NDC 0228-2855-11). Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP. round tablet debossed round tablet debossed round tablet debossed round tablet debossed
More pills like ROUND 853